Amyotrophic lateral sclerosis (ALS) is a devastating neurological disorder of unknown cause, in which motor nerve cells of ...

Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...

The No Labels political organization is taking a serious look at backing Mike Duggan's independent bid for Michigan governor in 2026, a move that would give him access to a nationwide network of ...

Wrist-based accelerometry may be a feasible method for continuous monitoring for individuals with motor neuron disease, according to data published in eBioMedicine.“Actigraphy, which leverages ...

Ever wonder how we made it through childhood without a million warning labels? These everyday risks were obvious back then—so what changed?

Tech & Science Nanotherapy improves neuron survival in Alzheimer’s model The therapeutic molecules self-assemble into nanofibers, which bond to the neuron-killing proteins.

Gene Therapy Shows Long-Term Benefits in Pediatric Neuron Disease — Disease-modifying effect of arsa-cel in early metachromatic leukodystrophy appears durable ...

The open-label Phase 1/2 clinical trial was designed to evaluate the safety and preliminary efficacy of a single-dose administration of NRTX-1001 inhibitory neuron cell therapy for drug-resistant ...

Neuronos Ltd., a subsidiary of Beyond Air Inc.’s, has secured an initial $2 million in equity financing from private investors as part of a larger funding round. This investment will accelerate the ...

After No Labels abandoned its attempt to put forth a bipartisan presidential ticket back in April, many thought the group would have little influence going forward. During the 2024 election cycle ...